TEWKSBURY, Mass., Oct. 10, 2017 -- Omnify Software, a leading provider of web-based Product Lifecycle Management (PLM) software for discrete manufacturers, today announces that Axonics Modulation Technologies, Inc., a privately-held medical device company developing an innovative neuromodulation platform based on miniaturized rechargeable technology, has implemented the Empower PLM system to establish design controls for regulatory compliance.
Axonics wanted a software solution that would facilitate Active Implantable Medical Device (AIMD) product development under a Quality System compliant to ISO (International Organization for Standardization) 13485 and the FDA CFR (Code of Federal Regulations), as well as other regulatory frameworks. They selected Omnify Empower PLM because it offers a flexible and configurable system for small medical device companies. Implementation of Omnify Empower took only a few weeks and an ISO 13485-compliant Quality System was established within five months of the first DCO (Document Change Order) release. Axonics currently utilizes the Document Control, Bill of Material (BOM) management, Supplier Management, Training Management, and Equipment Management modules. They have also configured Omnify Empower to address areas such as: material citations, calibration and preventive maintenance, component characteristics, and Design History File (DHF) auto-generation.
“Omnify facilitates rapid design, document, and BOM controls in tandem with supplier approvals and vendor item linkages, allowing us to meet our ambitious timelines,” stated Joseluis Espinosa, Director, Quality Engineering for Axonics Modulation Technologies. “We were told by industry experts that a new Sacral Neuromodulation product would take five years to receive CE marking, but we accomplished that milestone in just two years after initiating design controls with Omnify Empower.”
“For growing medical device companies like Axonics that are bringing new products to market and are required to meet regulatory guidelines, depending on paper processes to manage product and compliance information could be detrimental to their business,” stated Chuck Cimalore, CTO for Omnify Software. “Our medical device customers adopt Empower PLM in order to gain an electronic, configurable system to establish design controls and to be able to prove out their processes for regulatory requirements.”
Read the full case study at: https://www.omnifysoft.com/customers/customer/axonics
About Omnify Software
Omnify Software, the leading provider of business-ready Product Lifecycle Management (PLM) solutions for discrete manufacturers, helps OEMs shorten development cycles, accelerate product innovation and improve bottom-line profitability. Omnify's commitment to customer success has resulted in a unique solution that is quick to implement, easy to use, and provides an open integration platform. Our web-based solution offers flexible deployment options that allow customers to deploy on-premises, in the cloud or via a hybrid approach. Omnify is well-known for superior customer service, delivering outstanding training, development and support with a team of experienced technology professionals. For more information about Omnify Software Product Lifecycle Management, please call 978-988-3800, email [email protected] or visit www.omnifysoft.com, LinkedIn, Twitter and YouTube; or subscribe to the Omnify Software RSS Feed.
Media Contact:
Alaine Portnoy
Omnify Software
[email protected]
978-988-3800
Valerie Harding
Ripple Effect Communications
[email protected]
617-536-8887


Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring 



